ABVX
Price
$88.03
Change
+$2.48 (+2.90%)
Updated
Sep 5 closing price
Capitalization
6.74B
One day until earnings call
IMNN
Price
$5.75
Change
+$0.04 (+0.70%)
Updated
Sep 5 closing price
Capitalization
14.51M
70 days until earnings call
Interact to see
Advertisement

ABVX vs IMNN

Header iconABVX vs IMNN Comparison
Open Charts ABVX vs IMNNBanner chart's image
Abivax SA
Price$88.03
Change+$2.48 (+2.90%)
Volume$3.2M
Capitalization6.74B
Imunon
Price$5.75
Change+$0.04 (+0.70%)
Volume$34.99K
Capitalization14.51M
ABVX vs IMNN Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. IMNN commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and IMNN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (ABVX: $88.03 vs. IMNN: $5.76)
Brand notoriety: ABVX and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 164% vs. IMNN: 14%
Market capitalization -- ABVX: $6.74B vs. IMNN: $14.51M
ABVX [@Biotechnology] is valued at $6.74B. IMNN’s [@Biotechnology] market capitalization is $14.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVX is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while IMNN’s TA Score has 3 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 4 bearish.
  • IMNN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both ABVX and IMNN are a bad buy in the short-term.

Price Growth

ABVX (@Biotechnology) experienced а +8.64% price change this week, while IMNN (@Biotechnology) price change was -2.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ABVX is expected to report earnings on Sep 08, 2025.

IMNN is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($6.74B) has a higher market cap than IMNN($14.5M). ABVX YTD gains are higher at: 1102.596 vs. IMNN (-53.556). IMNN has higher annual earnings (EBITDA): -14.79M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. IMNN (4.73M). IMNN has less debt than ABVX: IMNN (1.19M) vs ABVX (92.6M). ABVX (0) and IMNN (0) have equivalent revenues.
ABVXIMNNABVX / IMNN
Capitalization6.74B14.5M46,476%
EBITDA-170.04M-14.79M1,150%
Gain YTD1102.596-53.556-2,059%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M4.73M2,199%
Total Debt92.6M1.19M7,762%
FUNDAMENTALS RATINGS
IMNN: Fundamental Ratings
IMNN
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXIMNN
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 18 days ago
74%
Declines
ODDS (%)
Bearish Trend 20 days ago
86%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRECX41.860.50
+1.21%
Davis Real Estate C
HFMDX23.200.10
+0.43%
Hennessy Cornerstone Mid Cap 30 Inv
GFACX73.450.17
+0.23%
American Funds Growth Fund of Amer C
FRAAX60.81N/A
N/A
Franklin Growth Opportunities Adv
DNLCX54.49-0.01
-0.02%
BNY Mellon Active MidCap C

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+2.90%
IMNN - ABVX
57%
Loosely correlated
+0.61%
CLSD - ABVX
51%
Loosely correlated
-1.23%
ANEB - ABVX
46%
Loosely correlated
-0.42%
MLTX - ABVX
38%
Loosely correlated
-0.47%
XENE - ABVX
38%
Loosely correlated
+1.48%
More

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with REPL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+0.61%
REPL - IMNN
61%
Loosely correlated
+8.95%
ABVX - IMNN
57%
Loosely correlated
+2.90%
SPRO - IMNN
41%
Loosely correlated
+0.47%
MRUS - IMNN
36%
Loosely correlated
+1.87%
CLSD - IMNN
30%
Poorly correlated
-1.23%
More